Cargando…
A Genotypic Test for HIV-1 Tropism Combining Sanger Sequencing with Ultradeep Sequencing Predicts Virologic Response in Treatment-Experienced Patients
A tropism test is required prior to initiation of CCR5 antagonist therapy in HIV-1 infected individuals, as these agents are not effective in patients harboring CXCR4 (X4) coreceptor-using viral variants. We developed a clinical laboratory-based genotypic tropism test for detection of CCR5-using (R5...
Autores principales: | Kagan, Ron M., Johnson, Erik P., Siaw, Martin, Biswas, Pinaki, Chapman, Douglass S., Su, Zhaohui, Platt, Jamie L., Pesano, Rick L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459909/ https://www.ncbi.nlm.nih.gov/pubmed/23029482 http://dx.doi.org/10.1371/journal.pone.0046334 |
Ejemplares similares
-
SangeR: the high-throughput Sanger sequencing analysis pipeline
por: Schmid, Kai, et al.
Publicado: (2022) -
qSanger: Quantification of Genetic Variants in Bacterial Cultures by Sanger Sequencing
por: Prakash, Satya, et al.
Publicado: (2023) -
Determination of HIV-1 coreceptor tropism using proviral DNA in women before and after viral suppression
por: Baumann, Russell E, et al.
Publicado: (2015) -
A genotypic HIV-1 proviral DNA coreceptor tropism assay: characterization in viremic subjects
por: Brown, Jennifer, et al.
Publicado: (2014) -
Ultradeep Sequencing of a Human Ultraconserved Region Reveals Somatic and Constitutional Genomic Instability
por: De Grassi, Anna, et al.
Publicado: (2010)